VIR SCHEDULE 13D/A: SEC filing
An amendment to a Schedule 13D was
Filed with the SEC on · accession 0001012975-26-001020
VIR filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Nov 6, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +10.8% by the first close after the filing.
Summary of the filing
An amendment to a Schedule 13D was filed regarding Vir Biotechnology, Inc., but the filing text provided contains only the EDGAR directory listing and no substantive details about the transaction or ownership change.
Key details
How VIR stock reacted
Close before
$11.02
Nov 5, 2026
First close after
+10.80%
$12.21
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for VIR, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for VIR?
Click hereFrequently asked questions
What did VIR file with the SEC on Nov 6, 2026?
VIR filed a SCHEDULE 13D/A (SEC filing). An amendment to a Schedule 13D was filed regarding Vir Biotechnology, Inc., but the filing text provided contains only the EDGAR directory listing and no substantive details about the transaction or ownership change.
How do I read a SCHEDULE 13D/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).
How did VIR stock react to this filing?
VIR closed at $11.02 before the filing and $12.21 on Nov 6, 2026 (+10.80%).
Other VIR SEC filings
Get alerts when VIR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days